Cai et al., 2016 - Google Patents
Top-down proteomics: technology advancements and applications to heart diseasesCai et al., 2016
View HTML- Document ID
- 5179738416644966634
- Author
- Cai W
- Tucholski T
- Gregorich Z
- Ge Y
- Publication year
- Publication venue
- Expert review of proteomics
External Links
Snippet
Introduction: Heart diseases are a leading cause of morbidity and mortality for both men and women worldwide, and impose significant economic burdens on the healthcare systems. Despite substantial effort over the last several decades, the molecular mechanisms …
- 238000000575 proteomic 0 title abstract description 123
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for programme control, e.g. control unit
- G06F9/06—Arrangements for programme control, e.g. control unit using stored programme, i.e. using internal store of processing equipment to receive and retain programme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cai et al. | Top-down proteomics: technology advancements and applications to heart diseases | |
Brown et al. | Top-down proteomics: challenges, innovations, and applications in basic and clinical research | |
Arrell et al. | Cardiovascular proteomics: evolution and potential | |
Huguet et al. | Proton transfer charge reduction enables high-throughput top-down analysis of large proteoforms | |
Rosenberger et al. | Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS | |
Mallick et al. | Proteomics: a pragmatic perspective | |
Mann et al. | Proteomic analysis of post-translational modifications | |
Paša-Tolić et al. | Proteomic analyses using an accurate mass and time tag strategy | |
Köcher et al. | High precision quantitative proteomics using iTRAQ on an LTQ Orbitrap: a new mass spectrometric method combining the benefits of all | |
Schilling et al. | Multiplexed, scheduled, high-resolution parallel reaction monitoring on a full scan QqTOF instrument with integrated data-dependent and targeted mass spectrometric workflows | |
Conrads et al. | Utility of accurate mass tags for proteome-wide protein identification | |
Aebersold et al. | Mass spectrometry-based proteomics | |
Evans et al. | An insight into iTRAQ: where do we stand now? | |
Steen et al. | The ABC's (and XYZ's) of peptide sequencing | |
Kalxdorf et al. | IceR improves proteome coverage and data completeness in global and single-cell proteomics | |
Riley et al. | Enhanced dissociation of intact proteins with high capacity electron transfer dissociation | |
Kolli et al. | Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis | |
Gutstein et al. | Microproteomics: analysis of protein diversity in small samples | |
Mesri | Advances in proteomic technologies and its contribution to the field of cancer | |
Ji et al. | Quantitative proteome analysis using differential stable isotopic labeling and microbore LC− MALDI MS and MS/MS | |
Shliaha et al. | Middle-down proteomic analyses with ion mobility separations of endogenous isomeric proteoforms | |
Sokolowska et al. | Applications of mass spectrometry in proteomics | |
Schaffer et al. | Intact-mass analysis facilitating the identification of large human heart proteoforms | |
Chang et al. | Sequence-specific model for predicting peptide collision cross section values in proteomic ion mobility spectrometry | |
Luczak et al. | Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOF |